Found 48 matching trials
IXO+A in mCRC With Liver-only Metastases
PHASE2The percentage of patients with defined unresectable metastatic disease who...
Location
The Ottawa Hospital Cancer Center
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
PHASE2This is a single-arm, phase II study aiming to evaluate the feasibility and...
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC
PHASE2This prospective, single-arm, Phase II study aims to evaluate the efficacy,...
Location
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
PHASE2RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Location
Memorial Sloan-Kettering Cancer Center
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
PHASE2This study will evaluate the effectiveness and safety of HRS-4642 in combin...
Location
Jiangsu Province Hospital
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
PHASE1This study is a first-in-human, Phase 1/2, open label study that will evalu...
Location
University of Miami - Sylvester Comprehensive Cancer Center
AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer
PHASE2The goal of this clinical trial is to evaluate the efficacy and safety of A...
Location
Multiple Locations
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
PHASE2This is a prospective, single-center, single-arm, open phase II clinical st...
Location
Beijing Friendship Hospital, Capital Medical University
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
PHASE1The purpose of this study is to study how CMVIG interacts with the body and...
Location
University of Minnesota
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
PHASE1The toxicity of calcineurin inhibitors(CNI)is a major factor limiting the s...